GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (TSE:4587) » Definitions » ROE % Adjusted to Book Value

PeptiDream (TSE:4587) ROE % Adjusted to Book Value : -3.00% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PeptiDream ROE % Adjusted to Book Value?

PeptiDream's ROE % for the quarter that ended in Dec. 2024 was -18.09%. PeptiDream's PB Ratio for the quarter that ended in Dec. 2024 was 6.04. PeptiDream's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -3.00%.


PeptiDream ROE % Adjusted to Book Value Historical Data

The historical data trend for PeptiDream's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream ROE % Adjusted to Book Value Chart

PeptiDream Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.85 3.13 1.76 5.12

PeptiDream Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.09 -1.82 27.69 -0.35 -3.00

Competitive Comparison of PeptiDream's ROE % Adjusted to Book Value

For the Biotechnology subindustry, PeptiDream's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeptiDream's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PeptiDream's ROE % Adjusted to Book Value falls into.


;
;

PeptiDream ROE % Adjusted to Book Value Calculation

PeptiDream's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=30.92% / 6.04
=5.12%

PeptiDream's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-18.09% / 6.04
=-3.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PeptiDream ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PeptiDream's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PeptiDream Business Description

Industry
Traded in Other Exchanges
N/A
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.

PeptiDream Headlines

No Headlines